Cite
Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy
MLA
Shimokawa M, et al. “Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy.” Cancer Management and Research, vol. ume 14, Sept. 2022, pp. 2673–80. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.f9255455d744ee1be84236b6f90f036&authtype=sso&custid=ns315887.
APA
Shimokawa M, Haratake N, Takada K, Toyokawa G, Takamori S, Mizuki F, Takenaka T, & Hayashi T. (2022). Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy. Cancer Management and Research, ume 14, 2673–2680.
Chicago
Shimokawa M, Haratake N, Takada K, Toyokawa G, Takamori S, Mizuki F, Takenaka T, and Hayashi T. 2022. “Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy.” Cancer Management and Research ume 14 (September): 2673–80. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.f9255455d744ee1be84236b6f90f036&authtype=sso&custid=ns315887.